Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications

Ming Li, Ying Wang, Liang Cheng, Wanting Niu, Guoan Zhao, Jithin K. Raju, Jun Huo, Bin Wu, Bo Yin, Yongsheng Song, Renge Bu

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Renal cell carcinoma is one of the most common malignancy in adults, its prognosis is poor in an advanced stage and early detection is difficult due to the lack of molecular biomarkers. The identification of novel biomarkers for RCC is an urgent and meaningful project. Long non-coding RNA (lncRNA) is transcribed from genomic regions with a minimum length of 200 bases and limited protein-coding potential. Recently, lncRNAs have been greatly studied in a variety of cancer types. They participate in a wide variety of biological processes including cancer biology. In this review, we provide a new insight of the profiling of lncRNAs in RCC and their roles in renal carcinogenesis, with an emphasize on their potential in diagnosis, prognosis and potential roles in RCC therapy.

Original languageEnglish (US)
Pages (from-to)48424-48435
Number of pages12
JournalOncotarget
Volume8
Issue number29
DOIs
StatePublished - Jan 1 2017

Fingerprint

Long Noncoding RNA
Renal Cell Carcinoma
Biomarkers
Biological Phenomena
Neoplasms
Carcinogenesis
Kidney
Proteins
Therapeutics

Keywords

  • Diagnosis
  • LncRNA
  • Prognosis
  • Renal cell carcinoma
  • Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

Long non-coding RNAs in renal cell carcinoma : A systematic review and clinical implications. / Li, Ming; Wang, Ying; Cheng, Liang; Niu, Wanting; Zhao, Guoan; Raju, Jithin K.; Huo, Jun; Wu, Bin; Yin, Bo; Song, Yongsheng; Bu, Renge.

In: Oncotarget, Vol. 8, No. 29, 01.01.2017, p. 48424-48435.

Research output: Contribution to journalReview article

Li, M, Wang, Y, Cheng, L, Niu, W, Zhao, G, Raju, JK, Huo, J, Wu, B, Yin, B, Song, Y & Bu, R 2017, 'Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications', Oncotarget, vol. 8, no. 29, pp. 48424-48435. https://doi.org/10.18632/oncotarget.17053
Li, Ming ; Wang, Ying ; Cheng, Liang ; Niu, Wanting ; Zhao, Guoan ; Raju, Jithin K. ; Huo, Jun ; Wu, Bin ; Yin, Bo ; Song, Yongsheng ; Bu, Renge. / Long non-coding RNAs in renal cell carcinoma : A systematic review and clinical implications. In: Oncotarget. 2017 ; Vol. 8, No. 29. pp. 48424-48435.
@article{20836f7ca7f04871961a5893f63ebeaf,
title = "Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications",
abstract = "Renal cell carcinoma is one of the most common malignancy in adults, its prognosis is poor in an advanced stage and early detection is difficult due to the lack of molecular biomarkers. The identification of novel biomarkers for RCC is an urgent and meaningful project. Long non-coding RNA (lncRNA) is transcribed from genomic regions with a minimum length of 200 bases and limited protein-coding potential. Recently, lncRNAs have been greatly studied in a variety of cancer types. They participate in a wide variety of biological processes including cancer biology. In this review, we provide a new insight of the profiling of lncRNAs in RCC and their roles in renal carcinogenesis, with an emphasize on their potential in diagnosis, prognosis and potential roles in RCC therapy.",
keywords = "Diagnosis, LncRNA, Prognosis, Renal cell carcinoma, Therapy",
author = "Ming Li and Ying Wang and Liang Cheng and Wanting Niu and Guoan Zhao and Raju, {Jithin K.} and Jun Huo and Bin Wu and Bo Yin and Yongsheng Song and Renge Bu",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.17053",
language = "English (US)",
volume = "8",
pages = "48424--48435",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "29",

}

TY - JOUR

T1 - Long non-coding RNAs in renal cell carcinoma

T2 - A systematic review and clinical implications

AU - Li, Ming

AU - Wang, Ying

AU - Cheng, Liang

AU - Niu, Wanting

AU - Zhao, Guoan

AU - Raju, Jithin K.

AU - Huo, Jun

AU - Wu, Bin

AU - Yin, Bo

AU - Song, Yongsheng

AU - Bu, Renge

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Renal cell carcinoma is one of the most common malignancy in adults, its prognosis is poor in an advanced stage and early detection is difficult due to the lack of molecular biomarkers. The identification of novel biomarkers for RCC is an urgent and meaningful project. Long non-coding RNA (lncRNA) is transcribed from genomic regions with a minimum length of 200 bases and limited protein-coding potential. Recently, lncRNAs have been greatly studied in a variety of cancer types. They participate in a wide variety of biological processes including cancer biology. In this review, we provide a new insight of the profiling of lncRNAs in RCC and their roles in renal carcinogenesis, with an emphasize on their potential in diagnosis, prognosis and potential roles in RCC therapy.

AB - Renal cell carcinoma is one of the most common malignancy in adults, its prognosis is poor in an advanced stage and early detection is difficult due to the lack of molecular biomarkers. The identification of novel biomarkers for RCC is an urgent and meaningful project. Long non-coding RNA (lncRNA) is transcribed from genomic regions with a minimum length of 200 bases and limited protein-coding potential. Recently, lncRNAs have been greatly studied in a variety of cancer types. They participate in a wide variety of biological processes including cancer biology. In this review, we provide a new insight of the profiling of lncRNAs in RCC and their roles in renal carcinogenesis, with an emphasize on their potential in diagnosis, prognosis and potential roles in RCC therapy.

KW - Diagnosis

KW - LncRNA

KW - Prognosis

KW - Renal cell carcinoma

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=85024400716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024400716&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.17053

DO - 10.18632/oncotarget.17053

M3 - Review article

AN - SCOPUS:85024400716

VL - 8

SP - 48424

EP - 48435

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 29

ER -